• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    Nivagen`s Generic Remifentanil Hydrochloride Receives Approval in US

    28 Jun 2024 //

    FDA

    Enforcement Report - Week of April 24, 2019

    24 Apr 2019 //

    FDA

    Fresenius Kabi USA Generic Remifentanil Hydrochloride Receives Approval In US

    20 Jan 2018 //

    FDA

    Fresenius Kabi Usa`s Generic Remifentanil hydrochloride Receives Approval In US

    18 Jan 2018 //

    FDA

    Daiichi, Maruishi Pharma Introduce Generic Remifentanil IV Injection 2mg & 5mg

    10 Dec 2016 //

    PHARMABIZ

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.